OPS-FUEL, Inc. Competitors

Our greatest resource is our people. Their ingenuity, creativity and collaboration have met the complex challenges of energy’s past. Together, we’ll take on the future. We support the LinkedIn Terms of Use (User Agreement), and we expect visitors to our page to do the same. We encourage open, lively conversation with a few simple rules: --We reserve the right to correct factual errors. --We will reply to comments when appropriate. --If we disagree with other opinions, we will do so respectfully. --You may not post anything that is spam or that is abusive, profane, or defamatory toward a person, entity, belief, or symbol. --We will delete any posts that contain personal information such as email addresses, phone numbers and physical addresses, and other third party intellectual property material, when that information does not belong to the author of the post. --You may not post job listings for non-Chevron positions. --While we support lively, open discussion, we reserve the right to delete comments.

Check out our commenting guidelines 👉 bp.com/CommentsGuide

Quest Diagnostics (NYSE: DGX) empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our 47,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives. The company offers physicians the broadest test menu (3,000+ tests), is a pioneer in developing innovative new tests, is the leader in cancer diagnostics, provides anatomic pathology (AP) services, & interpretive consultation through its medical & scientific staff of about 900 M.D.s & Ph.D.s. Quest Diagnostics offers the most extensive clinical testing network in the U.S., with laboratories in most major metropolitan areas, & in Mexico, the UK & India. The company also operates four esoteric laboratories, 40 outpatient AP laboratories, & 160 smaller, rapid-response laboratories. Patients may have specimens collected in any of the company’s approximately 2,250 patient service centers. On a typical workday, testing is performed for about 550,000 patients. The company is the leading provider of pre-employment drugs-of-abuse screening for employers & risk assessment services for the life insurance industry. It is the world’s 2nd largest provider of clinical trials testing for new pharmaceuticals. More information is available at www.questdiagnostics.com. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery. Language Assistance / Non-Discrimination Notice Asistencia de Idiomas / Aviso de no Discriminación 語言協助 / 不歧視通知 www.QuestDiagnostics.com/home/nondiscrimination